Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL537229 | 1.00 | — | — | |
| Water SCHEMBL11252955 | 1.00 | — | — | |
| Water SCHEMBL11230437 | 0.94 | — | — | |
| SCHEMBL5821161 | 0.93 | — | — | |
| SCHEMBL4646 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL6308604 | 0.86 | — | — | |
| Ammonia Solution, Strong SCHEMBL634787 | 0.86 | — | — | |
| SCHEMBL309492 | 0.86 | — | — | |
| Fluoride SCHEMBL11853405 | 0.86 | — | — | |
| SCHEMBL15153745 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2490670-A2 | COMPOSITION FOR INHALATION | Innovata Limited (GB) | 2012-08-29 | — | — | EP | claimed |
| WO-2011048379-A2 | COMPOSITION | INNOVATA LIMITED (GB) | 2011-04-28 | — | — | WO | claimed |
| US-20020012687-A1 | Solid dose delivery vehicle and methods of making same | QDOSE LIMITED (GB) | 2002-01-31 | — | — | US | claimed |
| US-20130004542-A1 | COMPOSITION | INNOVATA LIMITED (GB) | 2013-01-03 | — | — | US | disclosed |
| EP-2490670-A2 | COMPOSITION FOR INHALATION | Innovata Limited (GB) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011048379-A2 | COMPOSITION | INNOVATA LIMITED (GB) | 2011-04-28 | — | — | WO | disclosed |
| US-7785631-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2010-08-31 | — | — | US | disclosed |
| US-7780991-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2010-08-24 | — | — | US | disclosed |
| US-7744925-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED | 2010-06-29 | — | — | US | disclosed |
| US-20080193546-A1 | SOLID DOSE DELIVERY VEHICLE AND METHODS OF MAKING SAME | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| US-7056495-B2 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LTD. (GB) | 2006-06-06 | — | — | US | disclosed |
| US-20040219206-A1 | Solid dose delivery vehicle and methods of making same | ROSER BRUCE J (GB) | 2004-11-04 | — | — | US | disclosed |
| US-6811792-B2 | SOLID SOLUTION OF BIOACTIVE MATERIAL IN GLASS; BOMBARDMENT ADMINISTERING | QUADRANT DRUG DELIVERY LTD. (GB) | 2004-11-02 | — | — | US | disclosed |
| US-20040052825-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2004-03-18 | — | — | US | disclosed |
| US-20030147961-A1 | Solid dose delivery vehicle and methods of making same | QUADRANT DRUG DELIVERY LIMITED (GB) | 2003-08-07 | — | — | US | disclosed |
| US-6565871-B2 | For administration of a bioactive material to subcutaneous and intradermal tissue | ELAN DRUG DELIVERY LTD. (GB) | 2003-05-20 | — | — | US | disclosed |
| US-20030054040-A1 | Solid solution of bioactive material in glass; bombardment administering | QUADRANT DRUG DELIVERY LIMITED (GB) | 2003-03-20 | — | — | US | disclosed |
| US-20020012687-A1 | Solid dose delivery vehicle and methods of making same | QDOSE LIMITED (GB) | 2002-01-31 | — | — | US | disclosed |
| US-6331310-B1 | THERAPEUTIC AGENT AND STABILIZING POLYOL, PREFERABLY THE DISSACCHARIDE TREHALOSE | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-12-18 | — | — | US | disclosed |
| US-6290991-B1 | POLYOL AND A BIOACTIVE AGENT WHEREIN SAID POLYOL IS AMORPHOUS OR NON-CRYSTALLINE AND STABILIZES SAID BIOACTIVE AGENT, AND WHEREIN SAID THERAPEUTIC COMPOSITION IS A POWDER SUITABLE FOR ADMINISTRATION BY INHALATION | QUANDRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-09-18 | — | — | US | disclosed |